Beijing Syngentech Co.

BiotechnologySeries ABeijing, Chinasyngentech.com.cn

Latest round

Series A

Last raised

Nov 2018

Total raised

Undisclosed

Investors

3

About Beijing Syngentech Co.

, LTD operates as a healthcare company that focuses on gene therapy and bio-pharmaceuticals research. The company’s main business revolves around providing cutting-edge synthetic biology services and products, including high-throughput gene function screening, drug resistance screening services, and CRISPR-Cas9 vector design. Its products are used in the fields of medical research, pharmaceutical development, and personalized healthcare solutions. The company generates revenue by providing its comprehensive suite of synthetic biology services and products to a diverse clientele in the scientific and healthcare sectors.

Who invested in Beijing Syngentech Co.

3 investors across 2 rounds

See all investors in Beijing Syngentech Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 19, 2018

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Dec 5, 2017

    Amount

    Undisclosed

    Investors

    Locked

Questions about Beijing Syngentech Co.

Who invested in Beijing Syngentech Co.?

Beijing Syngentech Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Beijing Syngentech Co. raised?

Beijing Syngentech Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Beijing Syngentech Co. last raise money?

Beijing Syngentech Co.'s most recent round on record is a Series A, in Nov 2018.

What does Beijing Syngentech Co. do?

, LTD operates as a healthcare company that focuses on gene therapy and bio-pharmaceuticals research.

Where is Beijing Syngentech Co. headquartered?

Beijing Syngentech Co. is headquartered in Beijing, China.

Which VCs invest in companies like Beijing Syngentech Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Syngentech Co.'s stage. Their profiles are linked below.

Raising like Beijing Syngentech Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.